Supernus Pharmaceuticals (S49.F) Q3 2024 Earnings

6AugConfirmed
Q4 2023
Q1 2024
Q2 2024
Q3 2024
-0.27
0.05
0.38
0.71

Details

Expected EPS
0.3569514
Actual EPS
0.70562152752
Surprise EPS
0.35
Surprise Percent
+97.68%

Description

Supernus Pharmaceuticals (S49.F) has reported earnings of 0.70562152752 per share for Q3 2024.

0 Comments

Share your thoughts